Keywords
Last Name
Institution

Robin H Bogner PhD

TitleAssociate Professor
InstitutionUniversity of Connecticut
DepartmentPharmaceutical Sciences
AddressUNIT 3092
Pharmacy/Bio, UNIT 3092
69 N Eagleville Road
Phone860-486-2136
Fax860-486-2076
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Forney-Stevens KM, Bogner RH, Pikal MJ. Addition of Amino Acids to Further Stabilize Lyophilized Sucrose-Based Protein Formulations: I. Screening of 15 Amino Acids in Two Model Proteins. J Pharm Sci. 2016 Feb; 105(2):697-704. PMID: 26414114.
      View in: PubMed
    2. Kleppe MS, Forney-Stevens KM, Haskell RJ, Bogner RH. Mathematical Models to Explore Potential Effects of Supersaturation and Precipitation on Oral Bioavailability of Poorly Soluble Drugs. AAPS J. 2015 Jul; 17(4):902-17. PMID: 25851513; PMCID: PMC4476993 [Available on 04/08/16].
    3. Grobelny P, Kazakevich I, Zhang D, Bogner R. Amorphization of itraconazole by inorganic pharmaceutical excipients: comparison of excipients and processing methods. Pharm Dev Technol. 2015 Jan; 20(1):118-27. PMID: 25312240.
      View in: PubMed
    4. Sugrue D, Bogner R, Ehret MJ. Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder. Am J Health Syst Pharm. 2014 Jul 15; 71(14):1163-70. PMID: 24973373.
      View in: PubMed
    5. Forney-Stevens KM, Pelletier MJ, Shalaev EY, Pikal MJ, Bogner RH. Optimization of a Raman microscopy technique to efficiently detect amorphous-amorphous phase separation in freeze-dried protein formulations. J Pharm Sci. 2014 Sep; 103(9):2749-58. PMID: 25275170.
      View in: PubMed
    6. Sahni EK, Bogner RH, Chaudhuri B. Systematic investigation of parameters affecting the performance of an agitated filter-dryer. J Pharm Sci. 2013 Jul; 102(7):2198-213. PMID: 23650096.
      View in: PubMed
    7. Qian KK, Wurster DE, Bogner RH. Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 3: effect of moisture. Pharm Res. 2012 Oct; 29(10):2698-709. PMID: 22430066.
      View in: PubMed
    8. Greco K, Bogner R. Solution-mediated phase transformation: significance during dissolution and implications for bioavailability. J Pharm Sci. 2012 Sep; 101(9):2996-3018. PMID: 22213419.
      View in: PubMed
    9. Qian KK, Bogner RH. Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems. J Pharm Sci. 2012 Feb; 101(2):444-63. PMID: 21976048.
      View in: PubMed
    10. Greco K, Bogner R. Solution-mediated phase transformation of haloperidol mesylate in the presence of sodium lauryl sulfate. AAPS PharmSciTech. 2011 Sep; 12(3):909-16. PMID: 21732157; PMCID: PMC3167271.
    11. Qian KK, Suib SL, Bogner RH. Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 2: amorphization capacity and mechanisms of interaction. J Pharm Sci. 2011 Nov; 100(11):4674-86. PMID: 21656521.
      View in: PubMed
    12. Murdande SB, Pikal MJ, Shanker RM, Bogner RH. Solubility advantage of amorphous pharmaceuticals, part 3: Is maximum solubility advantage experimentally attainable and sustainable? J Pharm Sci. 2011 Oct; 100(10):4349-56. PMID: 21630280.
      View in: PubMed
    13. Qian KK, Bogner RH. Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 1: thermodynamics of spontaneous amorphization. J Pharm Sci. 2011 Jul; 100(7):2801-15. PMID: 21337545.
      View in: PubMed
    14. Greco K, Mcnamara DP, Bogner R. Solution-mediated phase transformation of salts during dissolution: investigation using haloperidol as a model drug. J Pharm Sci. 2011 Jul; 100(7):2755-68. PMID: 21328581.
      View in: PubMed
    15. Hailu SA, Bogner RH. Complex effects of drug/silicate ratio, solid-state equivalent pH, and moisture on chemical stability of amorphous quinapril hydrochloride coground with silicates. J Pharm Sci. 2011 Apr; 100(4):1503-15. PMID: 24081473.
      View in: PubMed
    16. Goss S, Prushko J, Bogner R. Factors affecting calcium precipitation during neutralisation in a simulated intestinal environment. J Pharm Sci. 2010 Oct; 99(10):4183-91. PMID: 20737627.
      View in: PubMed
    17. Murdande SB, Pikal MJ, Shanker RM, Bogner RH. Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticals. Pharm Res. 2010 Dec; 27(12):2704-14. PMID: 20859662.
      View in: PubMed
    18. Bogner RH, Kleinebudde P, Nail S. Pharmaceutical review articles: from good to great. Pharm Dev Technol. 2010 Sep-Oct; 15(5):439-41. PMID: 20735298.
      View in: PubMed
    19. Qian KK, Bogner RH. Differential heat of adsorption of water vapor on silicified microcrystalline cellulose (SMCC): an investigation using isothermal microcalorimetry. Pharm Dev Technol. 2011 Nov-Dec; 16(6):616-26. PMID: 20722499.
      View in: PubMed
    20. Padilla AM, Ivanisevic I, Yang Y, Engers D, Bogner RH, Pikal MJ. The study of phase separation in amorphous freeze-dried systems. Part I: Raman mapping and computational analysis of XRPD data in model polymer systems. J Pharm Sci. 2011 Jan; 100(1):206-22. PMID: 20602453.
      View in: PubMed
    21. Hailu SA, Bogner RH. Solid-state surface acidity and pH-stability profiles of amorphous quinapril hydrochloride and silicate formulations. J Pharm Sci. 2010 Jun; 99(6):2786-99. PMID: 20091829.
      View in: PubMed
    22. Greco K, Bogner R. Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing. Mol Pharm. 2010 Oct 4; 7(5):1406-18. PMID: 20459092.
      View in: PubMed
    23. Murdande SB, Pikal MJ, Shanker RM, Bogner RH. Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement. Pharm Dev Technol. 2011 Jun; 16(3):187-200. PMID: 20429826.
      View in: PubMed
    24. Bose S, Bogner RH. Solventless visible light-curable coating: II. Drug release, mechanical strength and photostability. Int J Pharm. 2010 Jun 30; 393(1-2):41-7. PMID: 20371275.
      View in: PubMed
    25. Murdande SB, Pikal MJ, Shanker RM, Bogner RH. Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis. J Pharm Sci. 2010 Mar; 99(3):1254-64. PMID: 19697391.
      View in: PubMed
    26. Bose S, Bogner RH. Solventless visible light-curable coating: I. Critical formulation and processing parameters. Int J Pharm. 2010 Jun 30; 393(1-2):32-40. PMID: 20138131.
      View in: PubMed
    27. Greco K, Bergman TL, Bogner R. Design and characterization of a laminar flow-through dissolution apparatus: Comparison of hydrodynamic conditions to those of common dissolution techniques. Pharm Dev Technol. 2011 Feb; 16(1):75-87. PMID: 20105086.
      View in: PubMed
    28. Hailu SA, Bogner RH. Effect of the pH grade of silicates on chemical stability of coground amorphous quinapril hydrochloride and its stabilization using pH-modifiers. J Pharm Sci. 2009 Sep; 98(9):3358-72. PMID: 19363809.
      View in: PubMed
    29. Young JL, Bogner RH. Case report: lidocaine mucoadhesive buccal tablets for local relief of mouth ulcers. Int J Pharm Compd. 2009 May-Jun; 13(3):214-7. PMID: 23966474.
      View in: PubMed
    30. Goss S, Rafferty P, Prushko J, Gorman E, Taub M, Bogner R. Exploration of intestinal calcium precipitation as a barrier to absorption at high calcium doses. Pharm Res. 2008 Dec; 25(12):2760-8. PMID: 18560997.
      View in: PubMed
    31. Scagliarini M, Bogner RH. Pharmacy compounding at the university of connecticut: secundem artem et scientia. Int J Pharm Compd. 2008 May-Jun; 12(3):208-12. PMID: 23969708.
      View in: PubMed
    32. Bhatnagar BS, Pikal MJ, Bogner RH. Study of the individual contributions of ice formation and freeze-concentration on isothermal stability of lactate dehydrogenase during freezing. J Pharm Sci. 2008 Feb; 97(2):798-814. PMID: 17506511.
      View in: PubMed
    33. Bahl D, Bogner RH. Amorphization alone does not account for the enhancement of solubility of drug co-ground with silicate: the case of indomethacin. AAPS PharmSciTech. 2008; 9(1):146-53. PMID: 18446475; PMCID: PMC2976907.
    34. Bahl D, Hudak J, Bogner RH. Comparison of the ability of various pharmaceutical silicates to amorphize and enhance dissolution of indomethacin upon co-grinding. Pharm Dev Technol. 2008; 13(3):255-69. PMID: 18484494.
      View in: PubMed
    35. Goss SL, Lemons KA, Kerstetter JE, Bogner RH. Determination of calcium salt solubility with changes in pH and P(CO(2)), simulating varying gastrointestinal environments. J Pharm Pharmacol. 2007 Nov; 59(11):1485-92. PMID: 17976258.
      View in: PubMed
    36. Bose S, Bogner RH. Solventless photocurable film coating: evaluation of drug release, mechanical strength, and photostability. AAPS PharmSciTech. 2007; 8(3):E57. PMID: 17915807; PMCID: PMC2750553.
    37. Abdul-Fattah AM, Dellerman KM, Bogner RH, Pikal MJ. The effect of annealing on the stability of amorphous solids: chemical stability of freeze-dried moxalactam. J Pharm Sci. 2007 May; 96(5):1237-50. PMID: 17455341.
      View in: PubMed
    38. Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. Pharm Dev Technol. 2007; 12(5):505-23. PMID: 17963151.
      View in: PubMed
    39. Bose S, Bogner RH. Solventless pharmaceutical coating processes: a review. Pharm Dev Technol. 2007; 12(2):115-31. PMID: 17510883.
      View in: PubMed
    40. Bahl D, Bogner RH. Amorphization of Indomethacin by Co-Grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism. Pharm Res. 2006 Oct; 23(10):2317-25. PMID: 16927179.
      View in: PubMed
    41. Bhatnagar BS, Nehm SJ, Pikal MJ, Bogner RH. Post-thaw aging affects activity of lactate dehydrogenase. J Pharm Sci. 2005 Jun; 94(6):1382-8. PMID: 15858849.
      View in: PubMed
    42. Gupta MK, Vanwert A, Bogner RH. Formation of physically stable amorphous drugs by milling with Neusilin. J Pharm Sci. 2003 Mar; 92(3):536-51. PMID: 12587115.
      View in: PubMed
    43. Gupta MK, Tseng YC, Goldman D, Bogner RH. Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules. Pharm Res. 2002 Nov; 19(11):1663-72. PMID: 12458672.
      View in: PubMed
    44. Harianawala AI, Bogner RH, Bradley M. Measurement of pH near dissolving enteric coatings. Int J Pharm. 2002 Oct 24; 247(1-2):139-46. PMID: 12429492.
      View in: PubMed
    45. Gupta MK, Bogner RH, Goldman D, Tseng YC. Mechanism for further enhancement in drug dissolution from solid-dispersion granules upon storage. Pharm Dev Technol. 2002 Jan; 7(1):103-12. PMID: 11852693.
      View in: PubMed
    46. Gupta MK, Goldman D, Bogner RH, Tseng YC. Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent. Pharm Dev Technol. 2001 Nov; 6(4):563-72. PMID: 11775957.
      View in: PubMed
    47. Bogner RH, Szweijkowski J, Houston A. Release of morphine sulfate from compounded slow-release capsules: the effect of formulation on release. Int J Pharm Compd. 2001 Sep-Oct; 5(5):401-5. PMID: 23981979.
      View in: PubMed
    48. Jameel F, Mauri F, Bogner R. Identification and mass spectrometric sequence studies of fragments of l-asparaginase produced during freeze/thaw cycling. PDA J Pharm Sci Technol. 1998 May-Jun; 52(3):113-22. PMID: 9691674.
      View in: PubMed
    49. Jameel F, Bogner R, Mauri F, Kalonia D. Investigation of physicochemical changes to L-asparaginase during freeze-thaw cycling. J Pharm Pharmacol. 1997 May; 49(5):472-7. PMID: 9178179.
      View in: PubMed
    50. Jameel F, Kalonia D, Bogner R. The effect of hetastarch on the stability of L-asparaginase during freeze-thaw cycling. PDA J Pharm Sci Technol. 1995 May-Jun; 49(3):127-31. PMID: 7542144.
      View in: PubMed
    51. LaPorte SL, Harianawala A, Bogner RH. The application of malononitriles as microviscosity probes in pharmaceutical systems. Pharm Res. 1995 Mar; 12(3):380-6. PMID: 7617525.
      View in: PubMed
    Bogner's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _